Non-small cell lung cancer (NSCLC) continues to be a major health problem in the US. In 1990, approximately 120,000 new cases will be diagnosed, and the majority of these patients will have either unresectable disease or resected disease that has a relatively low chance of being cured. A variety of
Advanced non-small-cell lung cancer: adjunctive interferon γ in induction and maintenance therapy
✍ Scribed by C. Prior; S. Oroszy; W. Oberaigner; G. Ambrosch; A. Mohn-Staudner; W. Pfeifer; R. Pirker; H. Huber
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- English
- Weight
- 93 KB
- Volume
- 125
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Forty‐eight patients with small cell lung cancer were treated with an intensive therapy regimen which included induction chemotherapy with vincristine, adriamycin, procarbazine, and methotrexate. This was followed by radiation therapy given to areas of residual disease after restaging.
We designed our study to evaluate the safety and efficacy of simultaneous chemoradiation therapy in an accelerated, twice-a-day schedule to improve local control and survival in advanced lung cancer patients. Forty-one patients were entered into the study. Twenty-three had stage IIIB and 18 had stag
## Background and objectives: Incorporation of photodynamic therapy (pdt) into the induction therapy regimen utilized for treatment of locally advanced primary non-small cell bronchogenic carcinoma (nsclc) is explored. ## Study design/materials and methods: We present a retrospective review of 41